Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2013-A01440-45 | Other Identifier | ANSM |
Not provided
Not provided
failure to recruit
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Neuropathic pain is a medical condition involving allodynia (painful perceptions in response to stimuli that normally are not) and spontaneous pain (occurring at rest, without stimulation).
This pain is secondary to nervous system injury affecting the sensory system. The lesion is either at the nerve endings of the spinal cord or brain.
It induces a loss of sensitivity and likely reorganization of brain activity that are causing pain and which are the subject of this study.
Previous studies in functional neuroimaging has focused on brain areas activated during allodynic stimuli compared to non-painful stimuli. The abnormalities have been reported, but it was not possible to conclude formally. The authors failed to assess the part of the effect of the loss of sensory afferents (deafferentation) and the basal brain function.
Indeed, the operation without any sensory stimulation is not known yet is the initial level of activity which is the benchmark for studying brain function during stimulation. The objective of this study is to understand what are the cortical systems of allodynic dysfunctional in patients compared with controls at baseline.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| peripheric nervous lesion | Experimental | MRI scan |
|
| medullar or encephalic lesion | Experimental | MRI scan |
|
| control group | Other | MRI scan |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MRI scan | Radiation |
|
| Measure | Description | Time Frame |
|---|---|---|
| cerebral blood flow | quantified with MRI scan | at baseline |
| Measure | Description | Time Frame |
|---|---|---|
| rate of grey matter | difference between groups | at baseline |
| structure of the networks | Determine if structure of the networks is different between patients and controls. Measured with MRI scan. |
Not provided
Inclusion Criteria for patients :
Inclusion Criteria for witnesses :
Exclusion Criteria for 2 groups :
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Roland PEYRON, MD | CHU de SAINT-ETIENNE | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de SAINT-ETIENNE | Saint-Etienne | 42000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009437 | Neuralgia |
| ID | Term |
|---|---|
| D010523 | Peripheral Nervous System Diseases |
| D009468 | Neuromuscular Diseases |
| D009422 | Nervous System Diseases |
| D010146 | Pain |
Not provided
Not provided
| ID | Term |
|---|---|
| D009682 | Magnetic Resonance Spectroscopy |
| ID | Term |
|---|---|
| D013057 | Spectrum Analysis |
| D002623 | Chemistry Techniques, Analytical |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| at baseline |
| connection of the networks | Determine if connection of the networks is different between patients and controls. Measured with MRI scan. | at baseline |
| cortical loss | Assess the cortical loss of the patient group compared to controls. Measured with MRI scan. | at baseline |
| D009461 |
| Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |